Skip to main content
. 2019 Dec 21;21(1):93. doi: 10.3390/ijms21010093

Figure 4.

Figure 4

Longitudinal follow-up of Gal3C-S-OPN/uFL-OPN level in stone-free urolithiasis patients and residual-stone urolithiasis patients after URS. The urolithiasis-related aberrant glycosylation profile of OPN was analyzed by lectin array analysis. A 20-μL aliquot of concentrated urine was subjected to lectin chip analysis. (a) Longitudinal follow-up of Gal3C-S-OPN/uFL-OPN in stone-free urolithiasis patients after URS. (b) Longitudinal follow-up of Gal3C-S-OPN/uFL-OPN in residual-stone urolithiasis patients after URS. (c) Longitudinal follow-up of uFL-OPN in stone-free urolithiasis patients after URS. (d) Longitudinal follow-up of uFL-OPN in residual-stone urolithiasis patients after URS. Dashed black lines outline the cutoff value at 90% sensitivity as determined by a retrospective cohort.